Skip to main content
. 2019 Oct 23;8(11):1758. doi: 10.3390/jcm8111758

Figure 1.

Figure 1

Flow diagram of eligible study population. From the 80 screened patients, 51 patients had detectable EGFR mutation in their tissue samples. From these 51 patients, 40 patients who received treatment with a first-line EGFR TKI were enrolled in the outcome analysis. Abbreviations: EGFR = epidermal growth factor receptor; TKI = tyrosine kinase inhibitor.